Galapagos NV
GLPG
#5039
Rank
$1.86 B
Marketcap
$27.73
Share price
0.00%
Change (1 day)
-16.88%
Change (1 year)

Galapagos NV (GLPG) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : $0.13 Billion USD

According to Galapagos NV's latest financial reports the company's total liabilities are $0.13 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Galapagos NV - Total liabilities on balance sheet (from 2008 to 2026)

Total liabilities by year

Year Total liabilities Change
2024-12-31$1.28 B-25.34%
2023-12-31$1.72 B-27.11%
2022-12-31$2.36 B-17.97%
2021-12-31$2.88 B-22.96%
2020-12-31$3.74 B4.79%
2019-12-31$3.57 B1288.09%
2018-12-31$0.25 B-21.7%
2017-12-31$0.32 B-3.62%
2016-12-31$0.34 B302.89%
2015-12-31$84.75 M8.33%
2014-12-31$78.24 M-52.88%
2013-12-31$0.16 B7.4%
2012-12-31$0.15 B178.95%
2011-12-31$55.42 M-8.33%
2010-12-31$60.45 M21.15%
2009-12-31$49.9 M3.47%
2008-12-31$48.23 M-34.06%
2007-12-31$73.14 M-4.59%
2006-12-31$76.66 M216.84%
2005-12-31$24.19 M240.04%
2004-12-31$7.11 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
$116.09 B 84,143.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$57.72 B 41,791.69%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
$141.00 B 102,222.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$67.90 B 49,174.11%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
$87.81 B 63,627.20%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$65.46 B 47,404.77%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
$59.04 B 42,748.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
$0.11 B-19.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$32.10 B 23,194.12%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel